BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30890845)

  • 1. Choice of therapeutic anti-seizure medication in patients with brain tumour.
    Laghari AA; Ahmed SI; Qadeer N; Shamim MS
    J Pak Med Assoc; 2019 Mar; 69(3):442-444. PubMed ID: 30890845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
    van Breemen MS; Rijsman RM; Taphoorn MJ; Walchenbach R; Zwinkels H; Vecht CJ
    J Neurol; 2009 Sep; 256(9):1519-26. PubMed ID: 19434440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.
    van Breemen MS; Wilms EB; Vecht CJ
    Lancet Neurol; 2007 May; 6(5):421-30. PubMed ID: 17434097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
    Vecht C; Royer-Perron L; Houillier C; Huberfeld G
    Curr Pharm Des; 2017; 23(42):6464-6487. PubMed ID: 29076421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-epileptic drug and folic acid usage during pregnancy, seizure and malformation outcomes: Changes over two decades in the Kerala Registry of Epilepsy and Pregnancy.
    Keni RR; Jose M; A S R; Baishya J; Sankara Sarma P; Thomas SV
    Epilepsy Res; 2020 Jan; 159():106250. PubMed ID: 31855827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
    Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
    Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures in low- and high-grade gliomas: current management and future outlook.
    Vecht CJ; Wilms EB
    Expert Rev Anticancer Ther; 2010 May; 10(5):663-9. PubMed ID: 20469999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
    Panda SP; Dhurandhar Y; Agrawal M
    Mitochondrion; 2022 Sep; 66():27-37. PubMed ID: 35842181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glioma-associated epilepsy].
    Lian K; Engelsen B; Storstein A
    Tidsskr Nor Laegeforen; 2012 Aug; 132(15):1752-6. PubMed ID: 22929942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticonvulsant therapy for brain tumour-related epilepsy].
    Fröscher W; Kirschstein T; Rösche J
    Fortschr Neurol Psychiatr; 2014 Dec; 82(12):678-90. PubMed ID: 25489755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
    van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
    Epilepsia; 2021 May; 62(5):1119-1129. PubMed ID: 33735464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?
    Zaccara G; Lattanzi S; Brigo F
    Epilepsy Behav; 2021 Aug; 121(Pt A):108031. PubMed ID: 33992932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD; Bermejo PE; Gibbs AA; Huberfeld G; Kälviäinen R
    Epilepsy Behav; 2018 May; 82():91-103. PubMed ID: 29602083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of antiepileptic drug responses identifies drugs with potential efficacy for seizure control in Wolf-Hirschhorn syndrome.
    Ho KS; Markham LM; Twede H; Lortz A; Olson LM; Sheng X; Weng C; Wassman ER; Newcomb T; Wassman ER; Carey JC; Battaglia A
    Epilepsy Behav; 2018 Apr; 81():55-61. PubMed ID: 29477837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
    Gesche J; Hjalgrim H; Rubboli G; Beier CP
    Epilepsy Res; 2021 Feb; 170():106547. PubMed ID: 33421702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Youngerman BE; Choi H; Burke JF
    Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing antiepileptic drug treatment in tumoral epilepsy.
    Perucca E
    Epilepsia; 2013 Dec; 54 Suppl 9():97-104. PubMed ID: 24328881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure characteristics and the use of anti-epileptic drugs in children and young people with brain tumours and epileptic seizures: Analysis of regional paediatric cancer service population.
    Pilotto C; Liu JF; Walker DA; Whitehouse WP
    Seizure; 2018 May; 58():17-21. PubMed ID: 29609145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.